Psychemedics Corp.
General ticker "PMD" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $12.0M
Psychemedics Corp. does not follow the US Stock Market performance with the rate: -24.4%.
Estimated limits based on current volatility of 1.6%: low 2.19$, high 2.26$
Factors to consider:
- US accounted for 97.1% of revenue in the fiscal year ended 2022-12-31
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.04$, 4.97$]
- 2024-12-30 to 2025-12-30 estimated range: [2.15$, 5.13$]
Financial Metrics affecting the PMD estimates:
- Negative: Non-GAAP EPS, $ of -0.88 <= 0
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.37 <= 1.33
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of 2.16 <= 3.87
Short-term PMD quotes
Long-term PMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 |
|---|---|---|
| Operating Revenue | $25.24MM | $22.10MM |
| Operating Expenses | $26.32MM | $25.02MM |
| Operating Income | $-1.08MM | $-2.92MM |
| Non-Operating Income | $0.04MM | $-0.52MM |
| R&D Expense | $1.33MM | $1.14MM |
| Income(Loss) | $-1.04MM | $-3.44MM |
| Taxes | $0.04MM | $0.72MM |
| Profit(Loss)* | $-1.08MM | $-4.15MM |
| Stockholders Equity | $-10.08MM | $6.67MM |
| Assets | $18.73MM | $12.33MM |
| Operating Cash Flow | $4.89MM | $-1.48MM |
| Capital expenditure | $0.19MM | $0.16MM |
| Investing Cash Flow | $-0.21MM | $-0.16MM |
| Financing Cash Flow | $-1.92MM | $-1.15MM |
| Earnings Per Share** | $-0.19 | $-0.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.